In Vitro Activity of Omadacycline against Chlamydia pneumoniae | Zendy

Stephan Kohlhoff | Zendy; Natalia Huerta | Zendy; Margaret R. Hammerschlag | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

In Vitro Activity of Omadacycline against Chlamydia pneumoniae

Author(s) -

Stephan Kohlhoff,

Natalia Huerta,

Margaret R. Hammerschlag

Publication year - 2018

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01907-18

Subject(s) - moxifloxacin , levofloxacin , chlamydia , minimum inhibitory concentration , chlamydophila pneumoniae , in vitro , microbiology and biotechnology , azithromycin , antibacterial agent , doxycycline , gatifloxacin , chemistry , ofloxacin , chlamydiaceae , biology , antimicrobial , ciprofloxacin , antibiotics , immunology , biochemistry

The in vitro activities of omadacycline, azithromycin, doxycycline, moxifloxacin, and levofloxacin were tested against 15 isolates of Chlamydia pneumoniae The minimum inhibitory concentration at which 90% of the isolates of C. pneumoniae were inhibited by omadacycline was 0.25 μg/ml (range, 0.03 to 0.5 μg/ml).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research